InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies. More Details
Outstanding track record with flawless balance sheet.
Share Price & News
How has InMode's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: INMD is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: INMD's weekly volatility (7%) has been stable over the past year.
7 Day Return
US Medical Equipment
1 Year Return
US Medical Equipment
Return vs Industry: INMD exceeded the US Medical Equipment industry which returned 30.5% over the past year.
Return vs Market: INMD exceeded the US Market which returned 37.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is InMode's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StEstimating The Fair Value Of InMode Ltd. (NASDAQ:INMD)
4 weeks ago | Simply Wall StIs InMode Ltd.'s (NASDAQ:INMD) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
1 month ago | Simply Wall StThe InMode (NASDAQ:INMD) Share Price Is Up 194% And Shareholders Are Boasting About It
Is InMode undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: INMD ($113.67) is trading above our estimate of fair value ($93.48)
Significantly Below Fair Value: INMD is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: INMD is good value based on its PE Ratio (34.4x) compared to the US Medical Equipment industry average (65x).
PE vs Market: INMD is poor value based on its PE Ratio (34.4x) compared to the US market (18.4x).
Price to Earnings Growth Ratio
PEG Ratio: INMD is poor value based on its PEG Ratio (3.4x)
Price to Book Ratio
PB vs Industry: INMD is overvalued based on its PB Ratio (14x) compared to the US Medical Equipment industry average (4.6x).
How is InMode forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: INMD's forecast earnings growth (10.2% per year) is above the savings rate (2%).
Earnings vs Market: INMD's earnings (10.2% per year) are forecast to grow slower than the US market (14.9% per year).
High Growth Earnings: INMD's earnings are forecast to grow, but not significantly.
Revenue vs Market: INMD's revenue (16.3% per year) is forecast to grow faster than the US market (9.2% per year).
High Growth Revenue: INMD's revenue (16.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: INMD's Return on Equity is forecast to be high in 3 years time (25.9%)
How has InMode performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: INMD has high quality earnings.
Growing Profit Margin: INMD's current net profit margins (44.3%) are higher than last year (31.7%).
Past Earnings Growth Analysis
Earnings Trend: INMD's earnings have grown significantly by 55.2% per year over the past 5 years.
Accelerating Growth: INMD's earnings growth over the past year (154.6%) exceeds its 5-year average (55.2% per year).
Earnings vs Industry: INMD earnings growth over the past year (154.6%) exceeded the Medical Equipment industry 20%.
Return on Equity
High ROE: INMD's Return on Equity (38.5%) is considered high.
How is InMode's financial position?
Financial Position Analysis
Short Term Liabilities: INMD's short term assets ($375.3M) exceed its short term liabilities ($42.2M).
Long Term Liabilities: INMD's short term assets ($375.3M) exceed its long term liabilities ($9.7M).
Debt to Equity History and Analysis
Debt Level: INMD is debt free.
Reducing Debt: INMD has not had any debt for past 5 years.
Debt Coverage: INMD has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: INMD has no debt, therefore coverage of interest payments is not a concern.
What is InMode current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate INMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate INMD's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if INMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if INMD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of INMD's dividend in 3 years as they are not forecast to pay a notable one for the US market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Moshe Mizrahy (68 yo)
Mr. Moshe Mizrahy is a Co-founder of Home Skinovations Ltd. and serves as its Chairman and Chief Executive Officer. Mr. Mizrahy is also a Co-founder of InsightLook Technologies Ltd., Nizanim Venture Capita...
CEO Compensation Analysis
Compensation vs Market: Moshe's total compensation ($USD216.00K) is below average for companies of similar size in the US market ($USD5.32M).
Compensation vs Earnings: Moshe's compensation has been consistent with company performance over the past year.
Experienced Management: INMD's management team is seasoned and experienced (9 years average tenure).
Experienced Board: INMD's board of directors are not considered experienced ( 1.9 years average tenure), which suggests a new board.
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.2%.
InMode Ltd.'s company bio, employee growth, exchange listings and data sources
- Name: InMode Ltd.
- Ticker: INMD
- Exchange: NasdaqGS
- Founded: 2008
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$4.431b
- Shares outstanding: 38.19m
- Website: https://www.inmodemd.com
Number of Employees
- InMode Ltd.
- Tavor Building
- Sha’ar Yokneam
InMode Ltd. designs, develops, manufactures, and markets minimally-invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequenc...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/07/31 02:03|
|End of Day Share Price||2021/07/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.